136 related articles for article (PubMed ID: 32950495)
1. Determination of certain urinary microRNAs as promising biomarkers in diabetic nephropathy patients using gold nanoparticles.
Nossier AI; Shehata NI; Morsy SM; Saeed DF; Elsayed NM; Ismail MF; Eissa S
Anal Biochem; 2020 Nov; 609():113967. PubMed ID: 32950495
[TBL] [Abstract][Full Text] [Related]
2. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
Eissa S; Matboli M; Bekhet MM
Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
[TBL] [Abstract][Full Text] [Related]
3. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
[TBL] [Abstract][Full Text] [Related]
4. Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy.
Han Q; Zhang Y; Jiao T; Li Q; Ding X; Zhang D; Cai G; Zhu H
Nutr Diabetes; 2021 Jun; 11(1):24. PubMed ID: 34193814
[TBL] [Abstract][Full Text] [Related]
5. Urinary exosomal microRNA panel unravels novel biomarkers for diagnosis of type 2 diabetic kidney disease.
Eissa S; Matboli M; Aboushahba R; Bekhet MM; Soliman Y
J Diabetes Complications; 2016; 30(8):1585-1592. PubMed ID: 27475263
[TBL] [Abstract][Full Text] [Related]
6. Potential Value of Urinary Exosome-Derived let-7c-5p in the Diagnosis and Progression of Type II Diabetic Nephropathy.
Li W; Yang S; Qiao R; Zhang J
Clin Lab; 2018 May; 64(5):709-718. PubMed ID: 29739042
[TBL] [Abstract][Full Text] [Related]
7. miRNAs in Urine Extracellular Vesicles as Predictors of Early-Stage Diabetic Nephropathy.
Jia Y; Guan M; Zheng Z; Zhang Q; Tang C; Xu W; Xiao Z; Wang L; Xue Y
J Diabetes Res; 2016; 2016():7932765. PubMed ID: 26942205
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs from urinary extracellular vesicles are non-invasive early biomarkers of diabetic nephropathy in type 2 diabetes patients with the 'Asian Indian phenotype'.
Prabu P; Rome S; Sathishkumar C; Gastebois C; Meugnier E; Mohan V; Balasubramanyam M
Diabetes Metab; 2019 Jun; 45(3):276-285. PubMed ID: 30165157
[TBL] [Abstract][Full Text] [Related]
9. Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy.
Conserva F; Barozzino M; Pesce F; Divella C; Oranger A; Papale M; Sallustio F; Simone S; Laviola L; Giorgino F; Gallone A; Pontrelli P; Gesualdo L
Sci Rep; 2019 Aug; 9(1):11357. PubMed ID: 31388051
[TBL] [Abstract][Full Text] [Related]
10. Urinary miRNA-377 and miRNA-216a as biomarkers of nephropathy and subclinical atherosclerotic risk in pediatric patients with type 1 diabetes.
El-Samahy MH; Adly AA; Elhenawy YI; Ismail EA; Pessar SA; Mowafy ME; Saad MS; Mohammed HH
J Diabetes Complications; 2018 Feb; 32(2):185-192. PubMed ID: 29175120
[TBL] [Abstract][Full Text] [Related]
11. Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy.
Yang Y; Xiao L; Li J; Kanwar YS; Liu F; Sun L
Med Hypotheses; 2013 Aug; 81(2):274-8. PubMed ID: 23683774
[TBL] [Abstract][Full Text] [Related]
12. Urinary and Blood MicroRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: a Meta-Analysis.
Park S; Moon S; Lee K; Park IB; Lee DH; Nam S
Cell Physiol Biochem; 2018; 46(4):1331-1340. PubMed ID: 29689545
[TBL] [Abstract][Full Text] [Related]
13. Decreased Urine miR-199-3p may be a Potential Biomarker for Diabetic Nephropathy via Targeting Zinc Finger E-box-Binding Protein 1.
Meng L; Li G; Liu X; Jiang J; Zhu M; Sun Y
Clin Lab; 2018 Jul; 64(7):1177-1182. PubMed ID: 30146830
[TBL] [Abstract][Full Text] [Related]
14. A Novel Design Combining Isothermal Exponential Amplification and Gold-Nanoparticles Visualization for Rapid Detection of miRNAs.
Jiang J; Zhang B; Zhang C; Guan Y
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373308
[TBL] [Abstract][Full Text] [Related]
15. Identification, Confirmation, and Replication of Novel Urinary MicroRNA Biomarkers in Lupus Nephritis and Diabetic Nephropathy.
Cardenas-Gonzalez M; Srivastava A; Pavkovic M; Bijol V; Rennke HG; Stillman IE; Zhang X; Parikh S; Rovin BH; Afkarian M; de Boer IH; Himmelfarb J; Waikar SS; Vaidya VS
Clin Chem; 2017 Sep; 63(9):1515-1526. PubMed ID: 28667184
[TBL] [Abstract][Full Text] [Related]
16. Increased urinary miR-196a level predicts the progression of renal injury in patients with diabetic nephropathy.
An Y; Zhang C; Xu F; Li W; Zeng C; Xie L; Liu Z
Nephrol Dial Transplant; 2020 Jun; 35(6):1009-1016. PubMed ID: 30521014
[TBL] [Abstract][Full Text] [Related]
17. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
18. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
19. Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.
Lee SY; Choi ME
Pediatr Nephrol; 2015 Jul; 30(7):1063-75. PubMed ID: 25060761
[TBL] [Abstract][Full Text] [Related]
20. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
Liang S; Cai GY; Duan ZY; Liu SW; Wu J; Lv Y; Hou K; Li ZX; Zhang XG; Chen XM
BMC Nephrol; 2017 Feb; 18(1):63. PubMed ID: 28201996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
